Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
429.52
+1.47 (0.34%)
Jul 24, 2026, 3:23 PM EST
Roche Holding AG Financials Overview
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 62,959 | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |
Revenue Growth | -0.63% | 1.54% | 3.23% | -8.16% | -0.06% | 9.13% |
Gross Profit Gross Profit Growth | 46,339 | 46,711 | 46,112 | 44,084 | 46,077 | 46,203 |
Operating Income Operating Income Growth | 17,817 | 18,476 | 13,417 | 15,395 | 17,476 | 18,155 |
Net Income Net Income Growth | 12,341 | 12,880 | 8,277 | 11,498 | 12,421 | 13,930 |
Earnings Per Share EPS Growth | 15.33 | 16.04 | 10.31 | 14.31 | 15.37 | 16.20 |
EPS Growth | -4.43% | 55.58% | -27.95% | -6.90% | -5.12% | -1.94% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Roche Pharmaceuticals Roche Pharmaceuticals Growth | 44,496 | 44,787 | 43,297 | 40,520 | 40,602 | 43,434 |
Chugai Chugai Growth | 2,817 | 2,882 | 2,874 | 3,745 | 4,949 | 4,576 |
Diagnostics Diagnostics Growth | 13,623 | 13,847 | 14,324 | 14,451 | 17,730 | 17,840 |
Revenue (Total) Revenue (Total) Growth | 62,959 | 63,356 | 62,395 | 60,441 | 65,814 | 65,850 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 9,734 | 15,476 | 17,317 | 10,510 | 9,767 | 13,031 |
Total Debt Total Debt Growth | 31,805 | 31,636 | 34,654 | 29,209 | 25,351 | 31,198 |
Net Cash (Debt) Net Cash Growth | -22,071 | -16,160 | -17,337 | -18,699 | -15,584 | -18,167 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -27.42 | -20.12 | -21.62 | -23.26 | -19.29 | -21.12 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19,387 | 18,852 | 20,094 | 16,095 | 17,803 | 20,976 |
Capital Expenditures CapEx Growth | -3,638 | -3,748 | -3,529 | -3,742 | -3,449 | -3,693 |
Free Cash Flow Free Cash Flow Growth | 15,749 | 15,104 | 16,565 | 12,353 | 14,354 | 17,283 |
Free Cash Flow Growth | 4.27% | -8.82% | 34.10% | -13.94% | -16.95% | 14.93% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 73.60% | 73.73% | 73.90% | 72.94% | 70.01% | 70.16% |
Operating Margin | 28.30% | 29.16% | 21.50% | 25.47% | 26.55% | 27.57% |
Pretax Margin | 25.98% | 26.79% | 18.90% | 23.29% | 24.81% | 26.42% |
Profit Margin | 21.11% | 21.78% | 14.72% | 20.45% | 20.56% | 22.68% |
FCF Margin | 25.01% | 23.84% | 26.55% | 20.44% | 21.81% | 26.25% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 20.683 | 9.800 | 9.700 | 9.600 | 9.500 | 9.300 |
Dividend Per Share Growth | 14.07% | 1.03% | 1.04% | 1.05% | 2.15% | 2.20% |
Dividend Yield | 4.82% | 3.21% | 3.95% | 4.06% | 3.37% | 2.52% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 23.00 | 20.46 | 24.78 | 17.09 | 18.90 | 23.40 |
Forward PE | 17.02 | 16.19 | 12.72 | 12.49 | 14.05 | 18.19 |
P/FCF Ratio | 18.02 | 17.29 | 12.27 | 15.78 | 16.17 | 17.56 |
PS Ratio | 4.51 | 4.12 | 3.26 | 3.23 | 3.53 | 4.61 |